Stay updated on Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A new revision tag 'Revision: v3.5.5' is added, replacing the previous 'Revision: v3.5.4', reflecting an update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-06-05T21:43:53.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4. This reflects an updated version of the study record, without altering the reported study details.
    Difference
    0.1%
    Check dated 2026-05-15T16:02:02.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page footer revision was updated from v3.5.2 to v3.5.3, indicating a minor site/version update without changing the study information presented.
    Difference
    0.1%
    Check dated 2026-04-24T05:49:24.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:04:25.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No visible changes to the study details or page functionality.
    Difference
    0.1%
    Check dated 2026-03-18T22:53:15.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Revision updated: v3.4.2 removed; v3.4.3 added.
    Difference
    0.1%
    Check dated 2026-03-11T20:20:49.000Z thumbnail image

Stay in the know with updates to Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.